Company: TVRD
Filing Date: 2025-04-15
Form Type: 8-K
Source: 0001104659-25-035121
Chunk: 10

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-04-15
Form: 8-K
Item: Item 9.01
Chunk 10
---
            Registration Rights Agreement by and between the Company and the parties thereto, dated April 15, 2025.                                                                                               
  10.3†**          Exclusive License Agreement by and between the StemMed, Ltd. (f/k/a Stem Med Limited Partnership) and Baylor College of Medicine, dated July 16, 2012, as amended April 26, 2015, subject to Noti...  
  10.4†**          Exclusive License Agreement by and between the StemMed, Ltd. and Baylor College of Medicine, dated June 19, 2015, subject to Notice of Assignment from Stem Med Limited Partnership to Tvardi The...  

  10.5#**       Offer Letter by and between Imran Alibhai, Ph. D. and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.27 to the Registrant’s Registration Statement on Form S-4 (File No. 33...  
  10.6#**       Offer Letter by and between Dan Conn and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.28 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), fi...  
  10.7#**       Offer Letter by and between John Kauh, M. D. and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.29 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283...  
  10.8#**       Offer Letter by and between Jeffrey Larson, Ph. D., DABT and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.30 to the Registrant’s Registration Statement on Form S-4 (File...  
  10.9#**       Offer Letter by and between Yixin “ Joseph” Chen, Ph. D. and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.31 to the Registrant’s Registration Statement on Form S-4 (File...  
  10.10#*       Offer Letter by and between Stephen O’ Brien, MAcc, CPA and Tvardi Therapeutics, Inc.                                                                                                                 
  10.11#**      Tvardi Therapeutics, Inc. 2018 Stock Incentive Plan, as amended (